Or. Admin. Code § 855-115-0350

Current through Register Vol. 63, No. 10, October 1, 2024

Section 855-115-0350 - Services: Prescribing Practices - Short-acting Opioid Antagonists

(1) A Pharmacist may prescribe any FDA approved short-acting opioid antagonist (e.g., naloxone, nalmefene) and the necessary medical supplies to administer a short-acting opioid antagonist for opiate overdose:

(a) When dispensing any opiate or opioid prescription in excess of 50 morphine milligram equivalents (MME);

(b) To an individual seeking a short-acting opioid antagonist;

(c) To an entity seeking a short-acting opioid antagonist.

(2) A Pharmacist is not required to label the prescription according to OAR 855-041-1130 if dispensing a FDA approved short-acting opioid antagonist in the form of a nasal spray.

(3) The Pharmacist must document the encounter, the prescription and maintain records according to OAR 855-104-0055.

Or. Admin. Code § 855-115-0350

BP 26-2023, adopt filed 10/16/2023, effective 3/1/2024; BP 55-2024, amend filed 06/18/2024, effective 6/20/2024

Statutory/Other Authority: ORS 689.205

Statutes/Other Implemented: ORS 689.305, ORS 689.681, ORS 689.682 & ORS 689.684